在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human Soluble Receptor Activator of Nuclear Factor-kB,sRANK ELISA Kit

  • 中文名稱:
    人可溶性核因子κB受體活化因子(sRANK)酶聯免疫試劑盒
  • 貨號:
    CSB-E13539h
  • 規格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產品詳情

  • 產品描述:
    人可溶性核因子κB受體活化因子(sRANK)酶聯免疫試劑盒(CSB-E13539h)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿樣本中的TNFRSF11A含量。TNFRSF11A是一個重要靶點。它是腫瘤壞死因子受體超家族成員,在骨代謝、免疫調節等生理過程中發揮關鍵作用。其研究機制主要聚焦于它與配體結合激活信號通路,參與破骨細胞生成調控等,是相關疾病藥物研發的潛在靶點。試劑盒檢測范圍為0.312 ng/ml-20 ng/ml.,靈敏度為0.078 ng/ml.。適用于基礎科研中骨代謝調控機制研究、炎癥性疾病模型分析、腫瘤微環境探索等領域,尤其可為骨相關疾病生物標志物篩選、藥物干預效果評估提供可靠數據支持本品僅用于科研,不用于臨床診斷,產品具體參數及操作步驟詳見產品說明書。
  • 別名:
    CD 265 ELISA Kit; CD265 ELISA Kit; FEO ELISA Kit; LOH18CR1 ELISA Kit; Loss of heterozygosity 18 chromosomal region 1 ELISA Kit; mRANK ELISA Kit; ODFR ELISA Kit; OFE ELISA Kit; OPTB7 ELISA Kit; Osteoclast differentiation factor receptor ELISA Kit; OSTS ELISA Kit; Paget disease of bone 2 ELISA Kit; PDB 2 ELISA Kit; PDB2 ELISA Kit; RANK ELISA Kit; Receptor activator of NF KB ELISA Kit; Receptor activator of NF-KB ELISA Kit; receptor activator of nuclear factor kappa B ELISA Kit; TNF receptor superfamily member 11a ELISA Kit; TNFRSF11A ELISA Kit; TNR11_HUMAN ELISA Kit; TRANCER ELISA Kit; Tumor necrosis factor receptor superfamily member 11a NFKB activator ELISA Kit; Tumor necrosis factor receptor superfamily member 11a activator of NFKB ELISA Kit; Tumor necrosis factor receptor superfamily member 11A ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測范圍:
    0.3125 ng/ml- 20ng/ml
  • 靈敏度:
    0.078 ng/ml
  • 反應時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領域:
    Others
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:

    Intra-assay Precision (Precision within an assay): CV%<8%

    Three samples of known concentration were tested twenty times on one plate to assess.

    Inter-assay Precision (Precision between assays): CV%<10%

    Three samples of known concentration were tested in twenty assays to assess.

  • 線性度:

    To assess the linearity of the assay, samples were spiked with high concentrations of human sRANK in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.

     

    Sample

    Serum(n=4)

    1:1

    Average %

    90

    Range %

    86-94

    1:2

    Average %

    101

    Range %

    94-104

    1:4

    Average %

    91

    Range %

    85-94

    1:8

    Average %

    95

    Range %

    90-98

  • 回收率:

    The recovery of human sRANK spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.

    Sample Type

    Average % Recovery

    Range

    Serum (n=5)

    90

    84-94

    EDTA plasma (n=4)

    95

    89-98

  • 標準曲線:

    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

    ng/ml

    OD1

    OD2

    Average

    Corrected

    20

    1.981

    2.012

    1.997

    1.898

    10

    1.523

    1.514

    1.519

    1.420

    5

    0.886

    0.867

    0.877

    0.778

    2.5

    0.425

    0.445

    0.435

    0.336

    1.25

    0.290

    0.303

    0.297

    0.198

    0.625

    0.215

    0.222

    0.219

    0.120

    0.312

    0.154

    0.157

    0.156

    0.057

    0

    0.100

    0.098

    0.099

     

  • 數據處理:
  • 貨期:
    3-5 working days

產品評價

平均分:
5.0分 - 1 個評價

樣品類型:血清

樣品信息:人

稀釋比:沒有稀釋

產品評價: 用sRANK-elisa試劑盒檢測正常人和病人的血清樣品,正常組OD值很低,比0孔稍高。病人組偶爾有幾個樣品OD值很高。結果正常。

By 劉老師

靶點詳情

  • 功能:
    Receptor for TNFSF11/RANKL/TRANCE/OPGL; essential for RANKL-mediated osteoclastogenesis. Involved in the regulation of interactions between T-cells and dendritic cells.
  • 基因功能參考文獻:
    1. Reduced miR-144-3p expression in serum and bone mediates osteoporosis pathogenesis by targeting RANK. PMID: 29334613
    2. findings indicate that C/EBPalpha is a stronger inducer of osteoclast differentiation than c-Fos, partly via C/EBPalpha regulation by the RANK (535)IVVY(538) motif PMID: 29122885
    3. gammadelta T cells suppressed iDCs osteoclastogenesis by downregulation of the RANK/cFos/ATP6V0D2 signaling pathway. PMID: 30066839
    4. RANK protein expression increased from normal to malignant endometrium, and the expression level was related with tumor grade but not with stage or the age of subjects in endometrial cancer. PMID: 29932437
    5. study identified the second disease gene for DOS. TNFRSF11A isoforms may have the different roles in skeletal development and metabolism PMID: 29568001
    6. The mRNA expression of RANK was highest in prostate tumour tissue from patients with bone metastases as compared to BPH or locally confined tumours, also shown in clinical subgroups distinguished by Gleason Score or PSA level. PMID: 29204705
    7. RANK 575C>T polymorphisms did not show any statistically significant differences between the study groups (Osteoporosis and Osteopenia) and Postmenopausal women. PMID: 27304650
    8. For the RANK gene, the AGTGC haplotype was associated with the lowest risk of presenting chronic joint pain in individuals without TMD (P=0.03). This study supports the hypothesis that changes in the OPG and RANK genes influence the presence of chronic joint pain in individuals with and without TMD. PMID: 28464982
    9. In this study, whole exome sequencing (WES) was successfully used in six patients with malignant infantile osteopetrosis (MIOP) and identified mutations in four MIOP-related genes (CLCN7, TCIRG1, SNX10, and TNFRSF11A). PMID: 27187610
    10. RANK is increased in hormone receptor negative and basal breast cancer, and correlates with worse recurrence-free survival and risk of bone metastasis. PMID: 28577080
    11. RANK SNP rs34945627 has a high allelic frequency in patients with breast cancer and Bone metastases, and is associated with decreased disease-free survival and Overall Survival. PMID: 27191503
    12. RANK rewires energy homeostasis in human lung cancer cells and promotes expansion of lung cancer stem-like cells. PMID: 29118048
    13. EGFR and RANK combinatorial in vitro analyses revealed a significant upregulation of AKT and ERK signaling after EGF stimulation in cell lines and also an increase of breast cancer cell invasiveness. PMID: 29025596
    14. In histologically normal tissue of BRCA1-mutation carriers and showed that RANK(+) cells are highly proliferative, have grossly aberrant DNA repair and bear a molecular signature similar to that of basal-like breast cancer. PMID: 27322743
    15. Vav3 is a novel TRAF6 interaction partner that functions in the activation of cooperative signaling between T6BSs and the IVVY motif in the RANK signaling complex. PMID: 27507811
    16. RANK and CCR6 expressed on monocytes may be novel targets for the regulation of bone resorption in rheumatoid arthritis and osteoporosis. PMID: 27822475
    17. High RANK expression is associated with endometrial metastasis. PMID: 26734994
    18. Study showed that endogenous RANK expression changes might influence prostate cancer cell behavior since reduced RANK expression resulted in significantly increased PC-3 cell proliferation and adhesion. PMID: 26977008
    19. genetic variation associated with hypertension in Chinese women PMID: 25810067
    20. we could not identify any association between external apical root resorption and two SNPs, rs1805034 from TNFRSF11A (encoding RANK) and rs3102735 from TNFRSF11B (encoding OPG). PMID: 24118270
    21. Results suggest that Cbl-b improves the prognosis of RANK-expressing breast cancer patients by inhibiting RANKL-induced breast cancer cell migration and metastasis. PMID: 26087197
    22. Based on our findings, the functional SNP RANK rs1805034 T>C may be an indicator for individual susceptibility to GCA. PMID: 26451891
    23. Functional polymorphisms RANK rs1805034 T>C may be an indicator for individual susceptibility to esophageal squamous cell carcinoma. PMID: 25019155
    24. These findings indicate that epidermal leukocytes gradually acquire RANK during gestation - a phenomenon previously observed also for other markers on LCs in prenatal human skin. PMID: 25722033
    25. this study is the first to identify RANK overexpression as a novel esophageal cancer marker in both Kazakh and Han ethnic esophageal squamous cell carcinoma patients. PMID: 25973136
    26. RANK/OPG ratio of expression in primary ccRCC is associated with BM. PMID: 26528707
    27. Three single nucleotide polymorphisms of TNFRSF11A (rs4500848, rs6567270 and rs1805034) are associated with Age at menarche and Age at natural menopause in Chinese women. PMID: 25884698
    28. Microcomputed tomography analysis demonstrated that the mice treated with rhRANK exhibited an increased bone volume and structure model index, and decreased trabecular spacing compared with those treated with rhOPG-Fc. PMID: 25738879
    29. results indicate that the RANK IVVY motif cooperates with the TRAF-binding motifs to promote osteoclastogenesis, which provides novel insights into the molecular mechanism of RANK signaling in osteoclastogenesis. PMID: 26276390
    30. Response to sRANKL in normal and tumor cells suggests a role for RANK/ERK-mediated signaling in normal osteoblasts chemotactic migration during bone remodeling that is altered or lost during osteosarcoma tumorigenesis. PMID: 25893522
    31. Higher RANK expression in the primary breast tumor is associated with a higher sensitivity to chemotherapy, but also a higher risk of relapse and death. PMID: 24737168
    32. Changes in bone markers, OPG, sRANKL and/or the OPG/sRANKL ratio exhibited by girls with Anorexia nervosa have been found to be associated with changes in the levels of the selected adipose tissue hormones. PMID: 24549600
    33. Genetic polymorphism in TNFRSF11A influences bone mineral density in post-menopausal women. PMID: 25138264
    34. Single nucleotide polymorphisms of RANK and PTGS1 show genetic associations with osteoproliferative changes in ankylosing spondylitis. PMID: 24651623
    35. he top hit rs17069906 (p = 5.6 e-10) is located within the genomic region of RANK, recently demonstrated to be an important player in the adaptive recovery response in podocytes and suggested as a promising therapeutic target in glomerular diseases. PMID: 25478860
    36. This review study has focused on the association of RANKL-RANK-OPG pathway in the pathogenesis and progression of giant cell tumor of bone as well as discussed the possible therapeutic strategies by targeting this pathway PMID: 25618600
    37. The urinary mRNA of RANK might be used to differentiate histologic subtypes of glomerulonephritis, particularly between minimal change disease and membranous nephropathy. PMID: 25171769
    38. RANKL and IL-6 mediate direct paracrine-autocrine signaling between cells of the osteoblast lineage and cancer cells. PMID: 24676805
    39. PGRN and PIRO form a new regulatory axis in osteoclastogenesis that is included in RANK signaling in cell fusion and OC resorption of osteoclastogenesis PMID: 25406312
    40. we identified RANK expression as a negative prognostic factor regarding disease-free survival in osteosarcoma PMID: 24842377
    41. High RANK protein expression is associated with breast cancer. PMID: 25111682
    42. RANKL, either derived from the prostate tumor or from the host, plays a key role in cancer bone metastasis. PMID: 24478054
    43. The involvement of TNFRSF11A in hereditary recurrent fever highlights the key role of this receptor in innate immunity. PMID: 24891336
    44. Mechanistic studies showed that IL-10 downregulated RANK expression in monocytes and thus, inhibited RANKL-induced OC formation PMID: 24340030
    45. silencing of miR-503 using a specific antagomir in ovariectomy (OVX) mice increased RANK protein expression, promoted bone resorption PMID: 23821519
    46. The genotypes, combined genotypes and allele frequencies of C421T and C575T polymorphisms of the RANK gene have not been found to be associated with bone mineral density in Turkish women. PMID: 23553199
    47. RANK signaling interferes with mammary cell commitment, contributing to breast carcinogenesis. PMID: 23766243
    48. High RANK expression is associated with Avascular Necrosis of Femur Head. PMID: 24200492
    49. The atrial expression of RANK (and RANKL/osteoprotegerin ratio) was higher in normal controls compared to persistent atrial fibrillation patients. PMID: 22178057
    50. One mechanism of RANK inhibition by 1,25(OH)2D3 is down-regulation of the M-CSF receptor c-Fms, which is required for the expression of RANK. PMID: 23116709

    顯示更多

    收起更多

  • 相關疾病:
    Familial expansile osteolysis (FEO); Paget disease of bone 2, early-onset (PDB2); Osteopetrosis, autosomal recessive 7 (OPTB7)
  • 亞細胞定位:
    [Isoform 1]: Cell membrane; Single-pass type I membrane protein.; [Isoform RANK-e5a]: Cell membrane; Single-pass type I membrane protein.
  • 組織特異性:
    Ubiquitous expression with high levels in skeletal muscle, thymus, liver, colon, small intestine and adrenal gland.
  • 數據庫鏈接:

    HGNC: 11908

    OMIM: 174810

    KEGG: hsa:8792

    STRING: 9606.ENSP00000465500

    UniGene: Hs.204044



主站蜘蛛池模板: 四虎成人永久在线精品免费| 天天摸天天碰天天添| 中文字幕精品无码一区二区| 亚洲一区无码中文字幕| 黄床片30分钟免费视频教程| 国产伦精品一区二区三区妓女| 99在线精品免费视频| 极品人妻被黑人中出种子| 在线精品亚洲一区二区小说| 亚洲成a v人片在线观看| 欧美一区二区| 一区二区精品视频日本| 色欲香天天综合网站| 亚洲熟妇无码av| 久久精品欧美日韩精品| 成人美女黄网站色大色费全看 | 在线观看片免费视频无码| 国产专区国产av| 青青草国产精品日韩欧美| 日韩欧美tⅴ一中文字暮| 中字幕一区二区三区乱码| 精品久久久久久国产| 亚洲va在线va天堂xxxx中文| 亚洲国产成人精品激情姿源 | 亚洲自偷自拍另类12p| 午夜人妻久久久久久久久| 欧美人与禽zoz0性伦交| 18禁区美女免费观看网站| 好疼太大了太粗太长了视频| 久久躁狠狠躁夜夜av| 午夜无码大尺度福利视频 | 欧美成aⅴ人高清免费| 大胆日本熟妇xxxx| 香港三级精品三级在线专区| 国产国拍精品av在线观看| 亚洲成av人片高潮喷水 | 久久人人爽人人爽人人片av高请 | 亚洲风影视传媒有限公司辽宁| 中文天堂国产最新| 国产三级在线观看免费| 顶级欧美做受xxx000|